← Back
product
Enhertu
Last discussed Oct 19, 2026
Trastuzumab deruxtecan, an antibody-drug conjugate from AstraZeneca and Daiichi Sankyo used to treat HER2-expressing breast and other cancers.
Recently discussed in
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Siddhartha Mukherjee · Oct 19, 2026
What creators say
SM
Siddhartha Mukherjee
mentioned
Used for: Later-line treatment of breast cancer
Praised: Works even after many prior lines of therapy have failed
"Two good examples are the use of a drug called Enhertu in breast cancer, which works even after many, many lines of therapies have stopped working."
More from Siddhartha Mukherjee →Keep exploring
Topics
About this data
- ✓45,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it